Travere Therapeutics, Inc. (TVTX) › Operating Cash FlowTravere Therapeutics, Inc. (TVTX) — Operating Cash FlowAnnual figures by period end, from SEC filings.2011-02-28: -$6892012-02-29: -$492012-12-31: -$2.74M2015-12-31: -$1.39M2016-12-31: -$3.44M2017-12-31: $7.40M2018-12-31: -$24.96M2019-12-31: -$58.21M2020-12-31: -$42.74M2021-12-31: -$14.79M2022-12-31: -$186.29M2023-12-31: -$280.02M2024-12-31: -$237.47M2025-12-31: $37.78M$37.78M2011-02-28Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31$37.78M—2026-02-19From 2025-01-012024-12-31-$237.47M—2026-02-19From 2024-01-012023-12-31-$280.02M—2026-02-19From 2023-01-012022-12-31-$186.29M—2025-02-21From 2022-01-012021-12-31-$14.79M—2024-02-20From 2021-01-012020-12-31-$42.74M—2023-02-23From 2020-01-012019-12-31-$58.21M—2022-02-24From 2019-01-012018-12-31-$24.96M-437.1%2021-03-01From 2018-01-012017-12-31$7.40M—2020-02-24From 2017-01-012016-12-31-$3.44M—2019-02-26From 2016-01-012015-12-31-$1.39M—2018-07-06From 2015-01-012012-12-31-$2.74M—2015-07-09From 2012-01-012012-02-29-$49—2012-05-24From 2011-03-022011-02-28-$689—2012-05-24From 2010-03-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)